List of insiders holdings for ANI PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | MERIDIAN VENTURE PARTNERS II LP Meridian Venture Partners II GP L.P. Meridian Venture Partners II Co. Brown Robert E. JR 10% Owner |
2025-03-13 20:50:29 | 1,184,570 0 |
1,184,570 | Form 13D |
2 | SIMES STEPHEN M Vice Chairman, President & CEO |
2012-01-27 16:29:26 | 800,000 202,267 |
1,002,267 | Form 4 |
3 | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
2025-02-18 20:19:58 | 92,588 637,620 |
730,208 | Form 4 |
4 | EDELMAN JOSEPH PERCEPTIVE LIFE SCIENCES MASTER FUND LTD PERCEPTIVE ADVISORS LLC Cho Michael 10% Owner |
2004-12-13 16:48:36 | 709,819 0 |
709,819 | Form 13G |
5 | EDELMAN JOSEPH PERCEPTIVE LIFE SCIENCES MASTER FUND LTD PERCEPTIVE ADVISORS LLC 10% Owner |
2004-12-13 16:48:36 | 709,819 0 |
709,819 | Form 13G |
6 | Lalwani Nikhil PRESIDENT & CEO |
2025-03-25 16:47:48 | 468,179 0 |
468,179 | Form 4 |
7 | MARSHBANKS TRACY Director |
2018-05-16 16:22:18 | 0 349,934 |
349,934 | Form 4 |
8 | DONENBERG PHILIP B Sr VP of Finance, CFO, Secy |
2012-01-27 16:33:48 | 329,322 0 |
329,322 | Form 4 |
9 | RAYNOR DANIEL Director |
2018-03-19 16:54:29 | 0 289,003 |
289,003 | Form 4 |
10 | Gassert Chad SVP - CORP. DEV. & STRATEGY |
2025-02-18 20:14:05 | 73,615 193,226 |
266,841 | Form 4 |
11 | PRZYBYL ARTHUR President and CEO |
2020-04-08 17:54:20 | 190,309 0 |
190,309 | Form 4 |
12 | CAREY STEPHEN P. SVP & CFO |
2025-03-25 16:44:49 | 180,863 0 |
180,863 | Form 4 |
13 | Snabes Michael C Sr. VP of Medical Affairs |
2012-01-27 16:37:45 | 165,000 0 |
165,000 | Form 4 |
14 | LEHMAN LEAH M VP, Product Development |
2005-08-25 15:16:38 | 150,000 0 |
150,000 | Form 4/A |
15 | Marken James G. SVP OPS & PROD DEV |
2024-06-11 16:51:43 | 117,829 0 |
117,829 | Form 4 |
16 | SHERWIN STEPHEN A Director |
2012-03-30 17:27:49 | 111,760 0 |
111,760 | Form 4 |
17 | Mutz Christopher HEAD OF RARE DISEASE |
2025-03-14 17:22:35 | 111,317 0 |
111,317 | Form 4 |
18 | Gutwerg Ori SVP, GENERICS |
2025-03-14 17:19:46 | 90,778 0 |
90,778 | Form 4 |
19 | Schrepfer Robert W SVP - NEW BUS DEV & SPEC SALES |
2021-03-29 20:11:23 | 87,477 0 |
87,477 | Form 4 |
20 | SULLIVAN LOUIS W Director |
2012-03-30 17:38:22 | 82,898 0 |
82,898 | Form 4 |
21 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. |
2025-04-14 16:17:11 | 80,145 0 |
80,145 | Form 4 |
22 | Jamnick Robert J. VP, Quality & Product Develop. |
2014-05-27 16:38:11 | 77,701 0 |
77,701 | Form 4 |
23 | Walsh Patrick D Director |
2024-05-23 20:03:53 | 74,712 0 |
74,712 | Form 4 |
24 | HO ANGELA Director |
2004-03-22 15:48:29 | 72,137 0 |
72,137 | Form 4 |
25 | Davis Krista SVP, CHIEF HR OFFICER |
2025-03-20 16:14:00 | 64,659 0 |
64,659 | Form 4 |
26 | Arnold Charlotte C. Vice President and CFO |
2016-04-11 19:10:16 | 62,298 0 |
62,298 | Form 4 |
27 | HAUGHEY THOMAS Director |
2024-05-23 19:45:47 | 51,526 0 |
51,526 | Form 4 |
28 | ROSENOW EDWARD C III Director |
2012-03-30 17:31:01 | 45,540 0 |
45,540 | Form 4 |
29 | Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS |
2025-03-04 17:15:04 | 45,465 0 |
45,465 | Form 4 |
30 | KJAER PETER Director |
2010-04-02 16:26:51 | 44,425 0 |
44,425 | Form 4 |
31 | Thoma Jeanne Director |
2024-05-23 20:02:18 | 40,609 0 |
40,609 | Form 4 |
32 | NASH DAVID Director |
2023-05-24 16:31:13 | 38,561 0 |
38,561 | Form 4 |
33 | Pera Antonio R Director |
2024-05-23 19:58:03 | 31,037 0 |
31,037 | Form 4 |
34 | POTTS JOHN T JR Director |
2012-03-30 17:34:41 | 27,657 2,924 |
30,581 | Form 4 |
35 | MANGANO ROSS J Director |
2014-09-16 16:40:57 | 26,914 0 |
26,914 | Form 4 |
36 | BELL STEVEN J VP Research & Pre-Clinical Dev |
2005-08-25 15:32:27 | 25,000 0 |
25,000 | Form 4/A |
37 | TANNENBAUM RENEE P Director |
2024-05-23 19:59:40 | 22,621 0 |
22,621 | Form 4 |
38 | Penn Thomas A. Director |
2019-04-01 16:00:21 | 16,710 0 |
16,710 | Form 4 |
39 | HOLUBOW FRED Director |
2018-03-22 17:00:35 | 16,144 0 |
16,144 | Form 4 |
40 | Leonard Matthew J Director |
2024-05-23 19:54:13 | 11,993 0 |
11,993 | Form 4 |
41 | LANKAU PETER A Director |
2016-04-11 18:58:16 | 4,500 0 |
4,500 | Form 4 |
42 | MORGENSTERN VICTOR A Director |
2007-06-14 16:53:13 | 0 0 |
0 | Form 4 |